Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II Clinical Trial

Official title:
A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).

Status Completed

Clinical Trial Summary

This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patients’ survival time following surgery for colon carcinoma Stage II.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Colon Cancer Stage II

Clinical Trial Details

NCT number	NCT00309543
Study type	Interventional
Source	Austrian Breast & Colorectal Cancer Study Group
Contact
Status	Completed
Phase	Phase 3
Start date	November 1993

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06434896` - Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial	N/A
Recruiting	`NCT04089631` - Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation	Phase 3
Active, not recruiting	`NCT05421702` - Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt	N/A
Recruiting	`NCT06108310` - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting	`NCT05194878` - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers	Phase 3